PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2065443
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2065443
According to Mordor Intelligence, the u.S. dialysis services market size is projected to expand from USD 30.65 billion in 2025 and USD 32.66 billion in 2026 to USD 44.85 billion by 2031, registering a CAGR of 6.55% between 2026 to 2031.

This report is Segmented by Modality (In-Center HD, Home HD, Peritoneal Dialysis), Site of Care (Freestanding, Hospital-Based, SNF, Patient Home), Service Type (Treatment Delivery, Home Training, Acute, Post-Acute, Care Coordination, Others), and Provider Type (LDOs, Independent, Nonprofit, Hospital-Affiliated, Nephrologist-Owned). The Market Forecasts are Provided in Terms of Value (USD).
The United States dialysis services market is growing steadily due to the increasing need for long-term renal replacement therapy. Between 2002 and 2022, end-stage kidney disease (ESKD) cases rose by 31.3%, with prevalence increasing by 20,000 cases annually. Over 808,000 Americans live with ESKD, and 68% depend on dialysis, creating a stable demand. Medicare coverage ensures financial stability, while CMS projects USD 6 billion in payments to 7,600 ESRD facilities by 2026, driving investments in clinical infrastructure. Providers focusing on long-term care management across diverse settings are better positioned for growth.
Diabetes and hypertension remain key drivers of renal disease in the United States, with aging demographics further compounding the burden. Black Americans face over four times the risk of developing ESKD compared to White Americans, while Hispanic and Native American populations are more than twice as likely to be affected. These disparities shape demand in specific regions, requiring providers to align staffing, referrals, and support services with local needs. Operators addressing high-burden populations through tailored expansions and care coordination are better equipped to manage growing patient volumes and ensure quality outcomes.
In 2026, workforce shortages continue to constrain the United States dialysis services market, as dialysis delivery relies on skilled nurses, technicians, and support staff. Nearly 25% of full-time nephrology social workers plan to resign within the year, highlighting staffing challenges that extend beyond direct care roles. CMS Conditions for Coverage mandate specific staffing and care protocols for ESRD facilities, making staffing gaps a critical issue affecting scheduling, compliance, and patient access. Rural areas face the greatest impact due to limited recruitment pools and travel distances, while smaller operators struggle with fewer resources to reassign staff. Persistent shortages may hinder capacity growth, particularly in fragile local markets.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
In 2025, In-Center Hemodialysis accounted for 65.35% of the United States dialysis services market, driven by established infrastructure, physician familiarity, and operational routines. Many patients begin and stabilize treatment in clinical settings before transitioning to home options. Fresenius Medical Care reported that nearly 90% of in-center dialysis machines in the United States are their devices, highlighting the role of equipment standardization. Peritoneal dialysis, while smaller in share, remains relevant as it enables treatment outside clinics while maintaining provider-patient relationships.
Home Hemodialysis is projected to grow at a 7.12% CAGR through 2031, making it the fastest-growing modality. CMS's expansion of home and self-dialysis training payments for acute kidney injury patients under the CY2025 ESRD PPS rule reduces cost barriers, encouraging providers to invest in home treatment systems. The market is shifting toward a balanced modality mix, emphasizing patient preparation and home support alongside treatment delivery. Fresenius plans to exit underperforming clinics in 2026 while advancing its 5008X CAREsystem rollout, reflecting network and technology optimization.
Freestanding Outpatient Dialysis Centers held a 69.67% share in 2025, maintaining their lead in the United States dialysis services market due to operational efficiency and scale under the ESRD PPS framework. CMS's 2026 payment increase of 2.2% for freestanding centers, compared to 1.5% for hospital-based facilities, further strengthens their economic position. Hospital-Based Dialysis Centers remain essential for higher-acuity patients and inpatient starts requiring closer monitoring.
Patient Home Dialysis is forecasted to grow at an 8.35% CAGR through 2031, driven by improved reimbursement, training payments, and portability. The CY2025 ESRD PPS rule's expansion of acute kidney injury home dialysis coverage supports this growth. Skilled nursing and post-acute settings also play a role, particularly for older and complex patients transitioning through multiple care settings. Future site-of-care dynamics will depend on seamless coordination of home onboarding, transport, and follow-up care.